rs376917645
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The NM_001182.5(ALDH7A1):c.575C>T(p.Thr192Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000682 in 1,614,040 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001182.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALDH7A1 | NM_001182.5 | c.575C>T | p.Thr192Met | missense_variant | 6/18 | ENST00000409134.8 | NP_001173.2 | |
ALDH7A1 | NM_001201377.2 | c.491C>T | p.Thr164Met | missense_variant | 6/18 | NP_001188306.1 | ||
ALDH7A1 | NM_001202404.2 | c.575C>T | p.Thr192Met | missense_variant | 6/16 | NP_001189333.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALDH7A1 | ENST00000409134.8 | c.575C>T | p.Thr192Met | missense_variant | 6/18 | 1 | NM_001182.5 | ENSP00000387123 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251476Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135914
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461886Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727244
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74326
ClinVar
Submissions by phenotype
Pyridoxine-dependent epilepsy Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 14, 2024 | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 192 of the ALDH7A1 protein (p.Thr192Met). This variant is present in population databases (rs376917645, gnomAD 0.007%). This missense change has been observed in individual(s) with epilepsy (PMID: 29655203; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 265033). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ALDH7A1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 19, 2024 | Variant summary: ALDH7A1 c.575C>T (p.Thr192Met) results in a non-conservative amino acid change located in the Aldehyde dehydrogenase domain (IPR015590) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 251476 control chromosomes (gnomAD). c.575C>T has been reported in the literature in individuals affected with Pyridoxine-Dependent Epilepsy (Lindy_2018, Couglin_2019, GIbaud_2021). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 29655203, 30043187, 33748042). ClinVar contains an entry for this variant (Variation ID: 265033). Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
not provided Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 01, 2021 | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Reported in a patient with epilepsy and/or a neurodevelopmental disorder, but additional information was not provided (Lindy et al., 2018); This variant is associated with the following publications: (PMID: 32956737, 30043187, 29655203) - |
ALDH7A1-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 02, 2024 | The ALDH7A1 c.575C>T variant is predicted to result in the amino acid substitution p.Thr192Met. This variant has been reported in multiple individuals with epilepsy and/or neurodevelopmental disorders (Lindy et al. 2018. PubMed ID: 29655203, table S4; Coughlin et al. 2019. PubMed ID: 30043187, Supp Table II). It was reported in the compound heterozygous state with a pathogenic variant in two individual in the literature (Coughlin CR 2nd et al. 2019. PubMed ID: 30043187, Supp Table II) and by a diagnostic lab in ClinVar, where it has classifications of uncertain and pathogenic (https://www.ncbi.nlm.nih.gov/clinvar/variation/265033/). This variant is reported in 0.0062% of alleles in individuals of African descent in gnomAD. Taken together, we classify this variant to be likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at